Other · developed by Bausch Health Americas
IDP-121 is a topical lotion studied in acne.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT02932306 | Phase 3 | Acne | Completed | BHC |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Acne
Updated Oct 25, 2026. Something wrong or missing? Report it on the BHC page.
See BHC's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
BHC catalysts and pipeline →